A new process suitable for large scale synthesis of the antitumor‐antiviral agent, 2‐β‐D‐ribofuranosyl‐4‐selenazolecarboxamide (selenazofurin, 1), has been developed. Thus, 1‐O‐acetyl‐2,3,5‐tri‐O‐benzoyl‐β‐D‐ribofuranose (3) was converted with cyanotrimethylsilane and stannic chloride to the crystalline 2,5‐anhydro‐3,4,6‐tri‐O‐benzoyl‐β‐D‐allononitrile (4) without chromatography. Cyanosugar 4 in ethanol was treated with hydrogen selenide gas to afford stereospecifically the unstable 2,5‐anhydro‐3,4,6‐tri‐O‐benzoyl‐β‐D‐allonoselenoamide (5) which was converted in situ by ethyl bromopyruvate to the stable ethyl 2‐(2,3,5‐tri‐O‐benzoyl‐β‐D‐ribofuranosyl)‐4‐selenazolecarboxylate (6). Selenazole ethyl ester 6 was deprotected with sodium methoxide affording methyl 2‐β‐D‐ribofuranosyl‐4‐selenazolecarboxylate (7) which was aminated with ammonia to provide selenazofurin (1) or with other amines to provide N‐substituted selenazofurin amides.